No profile data available.
Freenome, Inc. (FRNM) is a listed company, based in Brisbane, United States, with about 375 full-time employees.
Its market capitalization was $1.70 billion as of October 9, 2026.
Figures from company filings and market data; market data as of October 9, 2026.
, a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer.
$1.70 billion as of October 9, 2026.